“When-issued” trading expected to begin on or about June 12, 2024 Record date for distribution of GRAIL shares will be June 13, 2024 Distribution date for GRAIL shares anticipated to be June 24, 2024 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is […]
Limula founders: Luc Henry, CEO, Yann Pierson, CTO and Thomas Eaton, COO. Photograph CC-BY Jonathan Moy de Vitry RHRN.ch Limula leverages ‘Swiss Made’ engineering and an experienced team to brings much-needed innovation to the field of Cell and Gene Therapy. Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time, […]
· Led by Voima Ventures and co-led by existing investor Eir Ventures · Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to late formulation Stockholm, Sweden: ArgusEye, a provider of innovative sensor solutions for real-time monitoring of biological systems, today announced the close of its funding, raising […]
SAN CARLOS, Calif. — Cache DNA, Inc., a life sciences company revolutionizing biological sample and data storage infrastructure, today announced the closing of its seed round. The team raised an undisclosed amount from notable investors, including Climate Capital Bio, Exor Ventures, Hawktail, LifeX Ventures, Pillar VC, and Trousdale Ventures, including support from Illumina and founders […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results Preliminary revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. Instrument revenue of $19.0 million compared with $20.7 million in the prior-year […]
Isospec Analytics launches its breakthrough biomolecular analysis technology that identifies unknown molecules at scale for pharmaceutical, agritech and nutrition companies. Lausanne, Switzerland When developing new drugs, nutitional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, […]
WATERTOWN, Mass. — Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire”) has announced that it has closed a $2.0 million private placement with True Remainders Ltd. for the sale and issuance of (i) an aggregate of 1,538,461 shares of Spectaire common stock, and (ii) an accompanying warrant to purchase up to 1,538,461 shares of Spectaire common stock […]
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners to date, ranging from large pharmaceutical and biotechnology companies to leading academic institutions. CAMBRIDGE, Mass. — Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, […]
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 million) extension to its seed financing. The round was led by the Novalis […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
